Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU

Menu

BEIJING | CHINA

Partnering to deliver
global solutions
tailored to your unique needs

Transactions

Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 80 transactions and raising C$6.1 billion on behalf of our clients in Q1/231.2.

Filter our transactions* using the categories below:

Biorez, Inc.
Pending Completion

Biorez, Inc.

Financial Advisor (Sell side)
HEALTHCARE M&A ADVISORY US
View transaction detail
Amplifire
July 2022

Amplifire

Exclusive Financial Advisor to Amplifire, a Portfolio Company of Leeds Equity Partners, on its Acquisition by Polaris Growth Fund
HEALTHCARE TECHNOLOGY FINANCIAL SPONSORS M&A ADVISORY US
View transaction detail
Stratasan
July 2022

Stratasan

Financial Advisor to Stratasan on its Acquisition by Syntellis Performance Solutions, a Portfolio Company of Madison Dearborn Partners and Thoma Bravo
HEALTHCARE M&A ADVISORY FINANCIAL SPONSORS US
View transaction detail
Oncolytics Biotech
US$65m
June 2022

Oncolytics Biotech

Agent (ATM Offering)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Panbela Therapeutics
June 2022

Panbela Therapeutics

Exclusive Financial Advisor (Buy side)
HEALTHCARE M&A ADVISORY US
View transaction detail
Arcellx, Inc.
US$112m
June 2022

Arcellx, Inc.

Joint Bookrunner (Follow-On)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Cardiol Therapeutics
US$50m
June 2022

Cardiol Therapeutics

Lead Agent (ATM Offering)
HEALTHCARE EQUITY CAPITAL MARKETS CANADA US
View transaction detail
KemPharm, Inc.
May 2022

KemPharm, Inc.

Financial Advisor (Buy side)
HEALTHCARE M&A ADVISORY US DENMARK
View transaction detail
HEXO Corp.
US$40m
May 2022

HEXO Corp.

Agent (ATM Offering)
HEALTHCARE EQUITY CAPITAL MARKETS CANADA US
View transaction detail
Zynerba Pharmaceuticals
US$75m
May 2022

Zynerba Pharmaceuticals

Co-Agent (ATM Offering)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Rezolute, Inc.
US$130m
May 2022

Rezolute, Inc.

Co-Manager (Follow-On)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
RiteGene Technologies
April 2022

RiteGene Technologies

Exclusive Financial Advisor (Sell side)
HEALTHCARE CANNABIS M&A ADVISORY US
View transaction detail
  1. Company information as of June 30, 2022
  2. Transactions valued above C$1.5 million

* Transactions displayed here include transactions of Canaccord Genuity and its predecessors. The logos used in the tombstones represent Canaccord Genuity’s clients unless otherwise specified in the transaction description

How can we help?

If you would like to find out more about Canaccord Genuity or any of our services, please get in touch.